Uncommon Cents Investing’s Moderna MRNA Stock Holding History

Uncommon Cents Investing’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-50	Closed	-$3.34K	–	334
2024 Q3	$3.34K	Buy	+50	New	+$4.59K	﹤0.01%	402

Other funds holding MRNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Uncommon Cents Investing's MRNA Position: Q4 2024 in Review

Uncommon Cents Investing sold out of Moderna (MRNA) in Q4 2024, closing a stake of 50 shares — an estimated $3.34K sold.

Uncommon Cents Investing first reported a position in MRNA in Q3 2024 and held it in 1 quarter. The position peaked at $3.34K in Q3 2024. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

Uncommon Cents Investing reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
Uncommon Cents Investing sold 50 Moderna shares in Q4 2024, an estimated $3.34K.
Uncommon Cents Investing first reported a position in Moderna in Q3 2024 and held it in 1 quarter.
Uncommon Cents Investing's Moderna position peaked at $3.34K in Q3 2024.
745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Uncommon Cents Investing's 13F filing for Q4 2024, filed 16 Jan 2025.